SAFETY AND EFFICACY OF EZETIMIBE/SIMVASTATIN COMBINATION VERSUS ATORVASTATIN IN PATIENTS 65 YEARS OF AGE AND OLDER

被引：0
|
作者：
Foody, J. M. [1 ]
Brown, W. V. [2 ]
Zieve, F. [3 ,4 ]
Adewale, A. J. [5 ]
Flaim, D. [5 ]
Lowe, R. S. [5 ]
Jones-Burton, C. [5 ]
Tershakovec, A. M. [5 ]
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[3] McGuire VA Med Ctr, Richmond, VA USA
[4] Virginia Commonwealth Univ, Richmond, VA USA
[5] Merck & Co Inc, N Wales, PA USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70344-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P277
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [21] Prevention and Rehabilitation - Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
    Ballantyne, CM
    Abate, N
    Yuan, Z
    King, TR
    Palmisano, J
    AMERICAN HEART JOURNAL, 2005, 149 (03) : 464 - 473
  • [22] Ezetimibe/simvastatin versus atorvastatin for patients who have diabetes mellitus and hypercholesterolemia
    Abate, N
    Ballantyne, CM
    King, TR
    Yuan, Z
    Palmisano, J
    DIABETOLOGIA, 2005, 48 : A392 - A393
  • [23] Ezetimibe/simvastatin versus Atorvastatin for patients who have diabetes mellitus and hypercholesterolemia
    Ballantyne, CM
    Abate, N
    Yuan, Z
    King, TR
    Palmisano, J
    DIABETES, 2005, 54 : A235 - A235
  • [24] Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study
    Insull, William, Jr.
    Basile, Jan N.
    Vo, Anthony N.
    Jiang, Ping
    Thakkar, Roopal
    Padley, Robert J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (02) : 109 - 118
  • [25] Efficacy and safety of ezetimibe/simvastatin combination tablet compared with sinivastatin alone in patients with primary hypercholesterolemia
    Ose, L
    Bays, H
    Fraser, N
    Quinto, KL
    Reyes, R
    Sapre, A
    Tribble, D
    Donahue, SR
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 140 - 141
  • [26] The safety and efficacy of ezetimibe/simvastatin (E/S) versus atorvastatin (A) in hypercholesterolaemic (HC) patients with type 2 diabetes (T2DM)
    Mazzone, T.
    Goldberg, R. B.
    Guyton, J. R.
    Weinstock, R. S.
    Polis, A.
    Gazzara, R. A.
    Tomassini, J. E.
    Tershakovec, A. M.
    DIABETOLOGIA, 2006, 49 : 748 - 748
  • [27] Efficacy and safety of ezetimibe/simvastatin in elderly patients with primary hypercholesterolemia
    Feldman, T
    Fraser, N
    Shah, A
    Maccubbin, D
    Tribble, D
    Donahue, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 392A - 392A
  • [28] Lipid-altering efficacy and safety of ezetimibe/simvastatin versus rosuvastatin in patients with primary hypercholesterolemia
    Davidson, M. H.
    Catapano, A. L.
    Ballantyne, C. M.
    Brady, W. E.
    Gazzara, R. A.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 555 - 555
  • [29] The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia
    Kei, Anastazia A.
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 559 - 569
  • [30] Retrospective Study on Antihyperlipidemic Efficacy and Safety of Simvastatin, Ezetimibe and their Combination in Korean Adults
    Lee, Young-Hee
    Kim, Mi-Jeong
    Choi, Chang-Ik
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (08) : 1331 - 1337
12345